Clinical trial
Mucopolysaccharidosis I (MPS I) Registry
NCT00144794 · Genzyme, a Sanofi Company, Industry · Recruiting
Key facts
| NCT number | NCT00144794 |
|---|---|
| Title | Mucopolysaccharidosis I (MPS I) Registry |
| Official title | Mucopolysaccharidosis I (MPS I) Registry |
| Lead sponsor | Genzyme, a Sanofi Company, Industry |
| Status | Recruiting |
| Study type | Observational |
| Conditions | Mucopolysaccharidosis I (MPS I) |
| Enrollment | 1,500 |
| Start date | Nov 20, 2003 |
| Primary completion | Jan 31, 2034 |
| Completion | Jan 31, 2034 |
| First posted | Sep 5, 2005 |
| Last update posted | Oct 31, 2025 |
| Countries | Argentina, Australia, Belgium, Brazil, Canada, Chile, Colombia, Croatia, Czechia, Denmark, Egypt, France and 28 more |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: